Beta
387997

A comparative study of the analgesic efficacy of intraperitoneal instillation of diluted bupivacaine versus non-diluted bupivacaine after laparoscopic cholecystectomy, a prospect

Article

Last updated: 21 Dec 2024

Subjects

-

Tags

-

Abstract

Objective
Our study aims to compare the analgesic efficacy of intraperitoneal instillation of diluted versus non-diluted bupivacaine after laparoscopic cholecystectomy.
Methods
In this prospective, single-blinded, controlled and randomized study, we included 50 patients undergoing LC. They were randomly divided into two groups, with 25 patients each. At the end of surgery, the first group received intraperitoneal 20 ml bupivacaine 0.5% (100 mg), added to 480 ml normal saline, diluted bupivacaine group (DBG) and the second group received intraperitoneal 20 ml bupivacaine 0.5% (100 mg); non-diluted bupivacaine group (NBG). Pain was assessed and recorded using the visual analog scale (VAS) for 24 h. Time to the first analgesic request, total analgesic consumption in 24 h, incidence of negative effects after LC, such as nausea, vomiting and shoulder pain, any side effects due to local anesthetic used as hypotension, bradycardia or respiratory depression and hemodynamic parameters were also recorded.
Results
Postoperative VAS values were significantly lower in DBG than NBG in the 1 24 h ( value ≤ 0.003). The duration of analgesia (the 1 time analgesic request) was significantly longer in DBG (20.16 ± 3.52 h) than that in NBG (6.19 ± 2.93 h) ( value = 0.0001). Also, the total amount of postoperative analgesic consumption (tramadol) was less in DBG (7.2 ± 19.9 mg) than NBG (63 ± 31.16 mg) ( value = 0.0001). In relation to negative effects after LC, side effects due to analgesic drugs and hemodynamic parameters, the results were comparable in both groups.
Conclusion
Intraperitoneal instillation of diluted bupivacaine at the end of laparoscopic cholecystectomy decreases postoperative pain, delays request for rescue analgesia and reduces the amount of analgesics in the 1 24 h postoperatively, more than non-diluted bupivacaine, with comparable results in incidence-negative effects after LC, side effects due to analgesic drugs and comparable hemodynamic parameters.
Intraperitoneal (IP) bupivacaine instillation for postoperative analgesia after laparoscopic cholecystectomy (LC) has been reported in many studies as either diluted or non-diluted, with conflicting results and no standard recommendations.

DOI

TEJA-2023-0268

Keywords

Diluted bupivacaine, Intraperitoneal, Laparoscopic cholecystectomy, Analgesia

Authors

First Name

Mohamed

Last Name

Abdelraheem Mohamed

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Hitham MA.

Last Name

Elsayed

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Fawzy Abbas

Last Name

Badawy

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

40

Article Issue

1

Related Issue

51165

Issue Date

2024-12-01

Receive Date

2023-11-09

Publish Date

2024-12-31

Page Start

1

Page End

9

Print ISSN

1110-1849

Online ISSN

1687-1804

Link

https://egja.journals.ekb.eg/article_387997.html

Detail API

https://egja.journals.ekb.eg/service?article_code=387997

Order

387,997

Publication Type

Journal

Publication Title

Egyptian Journal of Anaesthesia

Publication Link

https://egja.journals.ekb.eg/

MainTitle

A comparative study of the analgesic efficacy of intraperitoneal instillation of diluted bupivacaine versus non-diluted bupivacaine after laparoscopic cholecystectomy, a prospective single-blinded controlled randomized study

Details

Type

Article

Created At

21 Dec 2024